Dashboard
High Management Efficiency with a high ROCE of 22.96%
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.10 times
Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 22.96%
Flat results in Sep 26
Stock is technically in a Mildly Bullish range
With ROCE of 13.1, it has a Very Expensive valuation with a 6.4 Enterprise value to Capital Employed
High Institutional Holdings at 30.68%
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Consistent Returns over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 176,240 Cr (Large Cap)
82.00
40
0.73%
0.61
11.84%
9.56
Total Returns (Price + Dividend) 
Latest dividend: 9 per share ex-dividend date: May-29-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Surge in Open Interest Signals Shifting Market Sentiment for Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. has witnessed a significant surge in open interest in its derivatives segment, reflecting a notable shift in market positioning and investor sentiment. This development, coupled with volume patterns and price movements, offers critical insights into potential directional bets and the evolving outlook for this large-cap pharmaceutical player.
Read More
Surge in Open Interest Signals Shifting Market Sentiment for Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting a significant shift in market positioning and investor sentiment. The pharmaceutical giant’s latest OI jumped by 18.17% to 44,084 contracts, signalling increased speculative activity and potential directional bets amid a backdrop of steady price gains and sector outperformance.
Read More
Surge in Open Interest Signals Shifting Market Sentiment for Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. has witnessed a notable 15.02% surge in open interest (OI) in its derivatives segment, reflecting a significant shift in market positioning. This increase, coupled with rising volumes and price outperformance, suggests evolving investor sentiment and potential directional bets in the large-cap pharmaceutical stock.
Read More Announcements 
Partial Redemption Of Ncds - INE685A07181
09-Nov-2026 | Source : BSEPartial Redemption of NCDs - INE685A07181
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Nov-2026 | Source : BSEIntimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of SEBI Listing Regulations
05-Nov-2026 | Source : BSEDisclosure under Regulation 30 of SEBI Listing Regulations
Corporate Actions 
No Upcoming Board Meetings
Torrent Pharmaceuticals Ltd. has declared 180% dividend, ex-date: 29 May 26
Torrent Pharmaceuticals Ltd. has announced 5:10 stock split, ex-date: 20 Feb 06
Torrent Pharmaceuticals Ltd. has announced 1:1 bonus issue, ex-date: 08 Jul 22
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 46 Schemes (8.82%)
Held by 836 FIIs (17.22%)
Torrent Investments Limited (formerly Known As Torrent Investments Private Limited) (60.78%)
Nps Trust (2.32%)
6.95%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 1.18% vs 17.25% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -5.65% vs 55.49% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.73% vs 9.46% in Sep 2024
Growth in half year ended Sep 2025 is 25.16% vs 19.11% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 14.33% vs 7.19% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 25.55% vs 17.07% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 21.40% vs 7.35% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.88% vs 15.40% in Mar 2025